Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
12.44
+0.41 (3.41%)
At close: Sep 18, 2025, 4:00 PM EDT
12.50
+0.06 (0.48%)
After-hours: Sep 18, 2025, 4:36 PM EDT
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $1.32 billion as of September 18, 2025. Its market cap has decreased by -12.60% in one year.
Market Cap
1.32B
Enterprise Value
527.00M
1-Year Change
-12.60%
Ranking
Category
Stock Price
$12.44
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $1.32B, an increase of 87.93%. That is a compound annual growth rate of 8.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 1.32B | -2.83% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 682.40B |
| Johnson & Johnson | 426.76B |
| AbbVie | 390.07B |
| UnitedHealth Group | 309.39B |
| Novo Nordisk | 260.64B |
| AstraZeneca | 241.43B |
| Novartis AG | 237.64B |
| Abbott Laboratories | 233.52B |